Article

Mechanisms Of LNP-Mediated mRNA Delivery

By Michael Nguyen, PhD

Lipid Nanoparticle mRNA Vaccine GettyImages-1418152448

Lipid nanoparticles (LNPs) have emerged as the premier option for mRNA delivery. Some aspects that make LNPs and mRNA a desirable pairing include how lipid layers form a protective shield around the mRNA that prevents enzymatic degradation by ribonucleases and the way LNPs form stable complexes with mRNA.

With mRNA-LNP vaccines paving the way, there have been recent FDA clearances for LNP-based gene editing clinical trials for rare diseases and cancer treatment. Explore the details supporting LNP-mediated mRNA delivery, as well as the challenges facing mRNA based therapeutics in the future.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online